1-3 of 3
Jonni S. Moore, PhD
Close
Sort by
Journal Articles

Pan-Anti-Apoptotic BCL-2 Family Inhibitor, Obatoclax, Activates Autophagic Cell Death Pathway and Has Potent Cytotoxicity in Infant and Pediatric MLL -Rearranged Leukemias

Alena Y. Zhang, PharmD, PhD, Blaine W. Robinson, PhD, Li-San Wang, PhD, Kajia Kao, PhD, Lori Cory, Jeffrey S. Barrett, PhD, Susan Atlas, PhD, I-Ming Chen, MS, Richard C. Harvey, PhD, Cheryl L. Willman, MD, Meenakshi Devidas, PhD, Andrew J. Carroll, PhD, Stephen P. Hunger, MD, Jonni S. Moore, PhD, Craig B. Thompson, MD, Mondira Kundu, MD, PhD, Carolyn A. Felix, MD
Journal: Blood
Blood (2008) 112 (11): 2647.
https://doi.org/10.1182/blood.V112.11.2647.2647
Published: 2008
Journal Articles

Pre-Clinical In Vitro Evaluation of BCL-2 Antisense Compound Genasense TM (G3139; Genta, Inc.) as a Targeted Pro-Apoptotic Agent for Leukemias with t(4;11)(q21;q23) Translocations.

Blaine W. Robinson, PhD, Kathyrn C. Behling, MD, PhD, Jeffrey S. Barrett, PhD, Manish Gupta, PhD, Jessicca M. Rege, PhD, Jonni S. Moore, PhD, Andrew D. Bantly, Junhyong Kim, PhD, George Hii, Cheryl L. Willman, MD, Jeffrey Potter, Peter C. Adamson, MD, Carolyn A. Felix, MD
Journal: Blood
Blood (2005) 106 (11): 3360.
https://doi.org/10.1182/blood.V106.11.3360.3360
Published: 2005
Journal Articles

Pan-BCL-2 Family Small Molecule Inhibitor GX015-070 (GeminX, Inc.) Exhibits Single Agent Cytotoxicity, Is Synergistic with Select Anti-Leukemia Cytotoxic Agents, and Induces Apoptosis in Cell Lines with t(4;11)(q21;q23) Translocations.

Jessicca M. Rege, PhD, Blaine W. Robinson, PhD, Manish Gupta, PhD, Jeffrey S. Barrett, PhD, Peter C. Adamson, MD, Kathryn C. Behling, MD, PhD, Andrew D. Bantly, Jonni S. Moore, PhD, Carolyn A. Felix, MD
Journal: Blood
Blood (2005) 106 (11): 3368.
https://doi.org/10.1182/blood.V106.11.3368.3368
Published: 2005